Skip to content
CorpDev.Org

CorpDev.Org

Daily News for Dealmakers

Monday 8th December 2025
  • Hire Me for M&A/PE Projects!
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities
CorpDev.Org

CorpDev.Org

Daily News for Dealmakers

  • Hire Me for M&A/PE Projects!
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities

Day: December 8, 2025

L’Oréal Doubles Down on Aesthetic Injectables with $4.7 Billion Stake Increase in Galderma

L’Oréal Doubles Down on Aesthetic Injectables with $4.7 Billion Stake Increase in Galderma

  • December 8, 2025
  • 0 Comments
  • By CorpDev
French beauty powerhouse L’Oréal has announced a strategic move to deepen its footprint in the fast-growing aesthetic injectables market by increasing its stake in Swiss dermatology leader...
Posted in Consumer and Industrial
Ryan Reynolds and Rob Mac Sell Minority Stake in Wrexham AFC to Apollo Sports Capital

Ryan Reynolds and Rob Mac Sell Minority Stake in Wrexham AFC to Apollo Sports Capital

  • December 8, 2025
  • 0 Comments
  • By CorpDev
Ryan Reynolds and Rob Mac, co-chairmen and controlling owners of Welsh football club Wrexham AFC, have sold a minority stake in the club to Apollo Sports Capital, the sports investment platform of...
Posted in Private Equity
Telefónica Pursues Strategic M&A in Four Core Markets to Drive Growth and Consolidation

Telefónica Pursues Strategic M&A in Four Core Markets to Drive Growth and Consolidation

  • December 8, 2025
  • 0 Comments
  • By CorpDev
Telefónica’s CEO and Executive Chairman, Marc Murtra, has confirmed that the Spanish telecommunications giant is actively engaged in merger and acquisition (M&A) discussions across its four key...
Posted in Technology, Media and Telecom
Mirum Pharmaceuticals Expands Rare Liver Disease Portfolio with $820 Million Bluejay Therapeutics Acquisition

Mirum Pharmaceuticals Expands Rare Liver Disease Portfolio with $820 Million Bluejay Therapeutics Acquisition

  • December 8, 2025
  • 0 Comments
  • By CorpDev
Mirum Pharmaceuticals (Nasdaq: MIRM), a leading rare disease biopharma, announced a definitive agreement to acquire Bluejay Therapeutics, a privately held biotech focused on viral and liver...
Posted in Healthcare and Life Sciences
SoftBank in Advanced Talks to Acquire DigitalBridge, Accelerating AI-Driven Digital Infrastructure Expansion

SoftBank in Advanced Talks to Acquire DigitalBridge, Accelerating AI-Driven Digital Infrastructure Expansion

  • December 8, 2025
  • 0 Comments
  • By CorpDev
SoftBank Group, led by CEO Masayoshi Son, is reportedly in advanced negotiations to acquire DigitalBridge Group Inc., a New York-listed private equity firm specializing in digital infrastructure...
Posted in Private Equity
Nuvision CEO Roger Ballard Highlights Strategic M&A Opportunities to Expand Regional Footprint and Member Services

Nuvision CEO Roger Ballard Highlights Strategic M&A Opportunities to Expand Regional Footprint and Member Services

  • December 8, 2025
  • 0 Comments
  • By CorpDev
Roger Ballard, CEO of Nuvision Credit Union, has articulated a clear vision for growth through mergers and acquisitions (M&A), leveraging recent successful integrations to enhance member value and...
Posted in Financial Services
Paramount Goes to War: The $108.4 Billion Hostile Bid for Warner Bros. Discovery Reshapes the Entertainment Landscape

Paramount Goes to War: The $108.4 Billion Hostile Bid for Warner Bros. Discovery Reshapes the Entertainment Landscape

  • December 8, 2025
  • 0 Comments
  • By CorpDev
On the morning of December 8, 2025, David Ellison's Paramount Skydance launched a dramatic escalation in what may prove to be the most significant media acquisition battle in a generation. By taking...
Posted in Technology, Media and Telecom
IBM’s $11 Billion Confluent Bet: The Real-Time Data Play That Reshapes Enterprise AI

IBM’s $11 Billion Confluent Bet: The Real-Time Data Play That Reshapes Enterprise AI

  • December 8, 2025
  • 0 Comments
  • By CorpDev
IBM's acquisition of Confluent for $11 billion announced on December 8, 2025, marks a watershed moment in how enterprise technology giants approach the competitive terrain of artificial intelligence...
Posted in Technology, Media and Telecom

CorpDev.Org

24×7 real time deals updates for everyone associated with deals.  Bookmark the page!

Daily M&A/PE News In 5 Min

Recent Posts

  • L’Oréal Doubles Down on Aesthetic Injectables with $4.7 Billion Stake Increase in Galderma
  • Ryan Reynolds and Rob Mac Sell Minority Stake in Wrexham AFC to Apollo Sports Capital
  • Telefónica Pursues Strategic M&A in Four Core Markets to Drive Growth and Consolidation
  • Mirum Pharmaceuticals Expands Rare Liver Disease Portfolio with $820 Million Bluejay Therapeutics Acquisition
  • SoftBank in Advanced Talks to Acquire DigitalBridge, Accelerating AI-Driven Digital Infrastructure Expansion

Categories

  • Hire Me for M&A/PE Projects!
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities

Daily M&A/PE News In 5 Min

Deals by month

  • December 2025 (23)
  • August 2025 (14)
  • July 2025 (78)
  • June 2025 (161)
  • May 2025 (163)
  • April 2025 (86)
  • January 2025 (53)
  • November 2024 (62)
  • October 2024 (102)
  • September 2024 (97)
  • August 2024 (165)
  • July 2024 (20)
  • March 2023 (7)
  • November 2022 (41)
  • October 2022 (89)
  • September 2022 (190)
  • August 2022 (80)
  • July 2022 (2)
  • June 2022 (79)
  • May 2022 (1)

Copyrights belong to 'Sources' referred to in each article, unless the articles are originally published by CorpDev.org in which case the copyright belongs to CorpDev.org